1
|
Moreno-Peral P, Conejo-Cerón S, Wijnen B, Lokkerbol J, Fernández A, Smit F, Bellón JÁ. Health-Economic Evaluation of Psychological Interventions for Anxiety Prevention: A Systematic Review. Psychiatr Serv 2024; 75:667-677. [PMID: 38410039 DOI: 10.1176/appi.ps.20230101] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/28/2024]
Abstract
OBJECTIVE Although evidence supports the effectiveness of psychological interventions for prevention of anxiety, little is known about their cost-effectiveness. The aim of this study was to conduct a systematic review of health-economic evaluations of psychological interventions for anxiety prevention. METHODS PubMed, PsycInfo, Web of Science, Embase, Cochrane Central Register of Controlled Trials, EconLit, National Health Service (NHS) Economic Evaluations Database, NHS Health Technology Assessment, and OpenGrey databases were searched electronically on December 23, 2022. Included studies focused on economic evaluations based on randomized controlled trials of psychological interventions to prevent anxiety. Study data were extracted, and the quality of the selected studies was assessed by using the Consensus on Health Economic Criteria and the Cochrane risk-of-bias tool. RESULTS All included studies (N=5) had economic evaluations that were considered to be of good quality. In two studies, the interventions showed favorable cost-effectiveness compared with usual care groups. In one study, the intervention was not cost-effective. Findings from another study cast doubt on the cost-effectiveness of the intervention, and the cost-effectiveness of the intervention in the remaining study could not be established. CONCLUSIONS Although the findings suggest some preliminary evidence of cost-effectiveness of psychological interventions for preventing anxiety, they were limited by the small number of included studies. Additional research on the cost-effectiveness of psychological interventions for anxiety in different countries and populations is required.
Collapse
Affiliation(s)
- Patricia Moreno-Peral
- IBIMA Plataforma BIONAND, Málaga, Spain (Moreno-Peral, Conejo-Cerón); Institute of Health Carlos III (ISCIII), Madrid (Moreno-Peral, Conejo-Cerón); Department of Personality, Evaluation and Psychological Treatment (Moreno-Peral) and Department of Public Health and Psychiatry (Bellón), University of Málaga, Málaga, Spain; Centre of Economic Evaluation and Machine Learning, Trimbos Institute, Utrecht, the Netherlands (Wijnen, Lokkerbol, Smit); Barcelona Agency of Public Health, Community Health Service, and Center for Biomedical Research in Epidemiology and Public Health, Barcelona, Spain (Fernández); Department of Clinical Neuro and Developmental Psychology, Vrije Universiteit Amsterdam, Amsterdam (Smit); El Palo Health Centre, Health District of Primary Care Málaga-Guadalhorce, Málaga, Spain (Bellón)
| | - Sonia Conejo-Cerón
- IBIMA Plataforma BIONAND, Málaga, Spain (Moreno-Peral, Conejo-Cerón); Institute of Health Carlos III (ISCIII), Madrid (Moreno-Peral, Conejo-Cerón); Department of Personality, Evaluation and Psychological Treatment (Moreno-Peral) and Department of Public Health and Psychiatry (Bellón), University of Málaga, Málaga, Spain; Centre of Economic Evaluation and Machine Learning, Trimbos Institute, Utrecht, the Netherlands (Wijnen, Lokkerbol, Smit); Barcelona Agency of Public Health, Community Health Service, and Center for Biomedical Research in Epidemiology and Public Health, Barcelona, Spain (Fernández); Department of Clinical Neuro and Developmental Psychology, Vrije Universiteit Amsterdam, Amsterdam (Smit); El Palo Health Centre, Health District of Primary Care Málaga-Guadalhorce, Málaga, Spain (Bellón)
| | - Ben Wijnen
- IBIMA Plataforma BIONAND, Málaga, Spain (Moreno-Peral, Conejo-Cerón); Institute of Health Carlos III (ISCIII), Madrid (Moreno-Peral, Conejo-Cerón); Department of Personality, Evaluation and Psychological Treatment (Moreno-Peral) and Department of Public Health and Psychiatry (Bellón), University of Málaga, Málaga, Spain; Centre of Economic Evaluation and Machine Learning, Trimbos Institute, Utrecht, the Netherlands (Wijnen, Lokkerbol, Smit); Barcelona Agency of Public Health, Community Health Service, and Center for Biomedical Research in Epidemiology and Public Health, Barcelona, Spain (Fernández); Department of Clinical Neuro and Developmental Psychology, Vrije Universiteit Amsterdam, Amsterdam (Smit); El Palo Health Centre, Health District of Primary Care Málaga-Guadalhorce, Málaga, Spain (Bellón)
| | - Joran Lokkerbol
- IBIMA Plataforma BIONAND, Málaga, Spain (Moreno-Peral, Conejo-Cerón); Institute of Health Carlos III (ISCIII), Madrid (Moreno-Peral, Conejo-Cerón); Department of Personality, Evaluation and Psychological Treatment (Moreno-Peral) and Department of Public Health and Psychiatry (Bellón), University of Málaga, Málaga, Spain; Centre of Economic Evaluation and Machine Learning, Trimbos Institute, Utrecht, the Netherlands (Wijnen, Lokkerbol, Smit); Barcelona Agency of Public Health, Community Health Service, and Center for Biomedical Research in Epidemiology and Public Health, Barcelona, Spain (Fernández); Department of Clinical Neuro and Developmental Psychology, Vrije Universiteit Amsterdam, Amsterdam (Smit); El Palo Health Centre, Health District of Primary Care Málaga-Guadalhorce, Málaga, Spain (Bellón)
| | - Anna Fernández
- IBIMA Plataforma BIONAND, Málaga, Spain (Moreno-Peral, Conejo-Cerón); Institute of Health Carlos III (ISCIII), Madrid (Moreno-Peral, Conejo-Cerón); Department of Personality, Evaluation and Psychological Treatment (Moreno-Peral) and Department of Public Health and Psychiatry (Bellón), University of Málaga, Málaga, Spain; Centre of Economic Evaluation and Machine Learning, Trimbos Institute, Utrecht, the Netherlands (Wijnen, Lokkerbol, Smit); Barcelona Agency of Public Health, Community Health Service, and Center for Biomedical Research in Epidemiology and Public Health, Barcelona, Spain (Fernández); Department of Clinical Neuro and Developmental Psychology, Vrije Universiteit Amsterdam, Amsterdam (Smit); El Palo Health Centre, Health District of Primary Care Málaga-Guadalhorce, Málaga, Spain (Bellón)
| | - Filip Smit
- IBIMA Plataforma BIONAND, Málaga, Spain (Moreno-Peral, Conejo-Cerón); Institute of Health Carlos III (ISCIII), Madrid (Moreno-Peral, Conejo-Cerón); Department of Personality, Evaluation and Psychological Treatment (Moreno-Peral) and Department of Public Health and Psychiatry (Bellón), University of Málaga, Málaga, Spain; Centre of Economic Evaluation and Machine Learning, Trimbos Institute, Utrecht, the Netherlands (Wijnen, Lokkerbol, Smit); Barcelona Agency of Public Health, Community Health Service, and Center for Biomedical Research in Epidemiology and Public Health, Barcelona, Spain (Fernández); Department of Clinical Neuro and Developmental Psychology, Vrije Universiteit Amsterdam, Amsterdam (Smit); El Palo Health Centre, Health District of Primary Care Málaga-Guadalhorce, Málaga, Spain (Bellón)
| | - Juan Ángel Bellón
- IBIMA Plataforma BIONAND, Málaga, Spain (Moreno-Peral, Conejo-Cerón); Institute of Health Carlos III (ISCIII), Madrid (Moreno-Peral, Conejo-Cerón); Department of Personality, Evaluation and Psychological Treatment (Moreno-Peral) and Department of Public Health and Psychiatry (Bellón), University of Málaga, Málaga, Spain; Centre of Economic Evaluation and Machine Learning, Trimbos Institute, Utrecht, the Netherlands (Wijnen, Lokkerbol, Smit); Barcelona Agency of Public Health, Community Health Service, and Center for Biomedical Research in Epidemiology and Public Health, Barcelona, Spain (Fernández); Department of Clinical Neuro and Developmental Psychology, Vrije Universiteit Amsterdam, Amsterdam (Smit); El Palo Health Centre, Health District of Primary Care Málaga-Guadalhorce, Málaga, Spain (Bellón)
| |
Collapse
|
2
|
Herbert KL, Brennan JMM. Use of Mobile Apps & Stepped-Care Model for Treating Depression in Primary Care. Prim Care 2023; 50:11-19. [PMID: 36822721 DOI: 10.1016/j.pop.2022.10.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/12/2023]
Abstract
Stepped-care (SC) models have been adopted in primary care settings as a method for treating mental health conditions within primary care. In a SC model, a patient's symptoms are assessed, and an intervention is prescribed that matches the severity of symptoms. Thus, the SC model offers a variety of steps and levels of treatment that range from low to high intensity. Progression in treatment is monitored on a weekly basis and patients are stepped up or down in level of care depending on their clinical response to the intervention.
Collapse
Affiliation(s)
- Krista L Herbert
- VA Portland Health Care System, 3710 Southwest US Veterans Hospital Road, Portland, OR 97239, USA.
| | | |
Collapse
|
3
|
van Dijk SEM, Pols AD, Adriaanse MC, van Marwijk HWJ, van Tulder MW, Bosmans JE. Cost-effectiveness of a stepped care program to prevent depression among primary care patients with diabetes mellitus type 2 and/or coronary heart disease and subthreshold depression in comparison with usual care. BMC Psychiatry 2021; 21:402. [PMID: 34389017 PMCID: PMC8361858 DOI: 10.1186/s12888-021-03367-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/03/2021] [Accepted: 06/10/2021] [Indexed: 11/30/2022] Open
Abstract
BACKGROUND Patients with diabetes mellitus type 2 (DM2) and/or coronary heart disease (CHD) are at high risk to develop major depression. Preventing incident major depression may be an important tool in reducing the personal and societal burden of depression. The aim of the current study was to assess the cost-effectiveness of a stepped care program to prevent major depression (Step-Dep) in diabetes mellitus type 2 and/or coronary heart disease patients with subthreshold depression in comparison with usual care. METHODS An economic evaluation with 12 months follow-up was conducted alongside a pragmatic cluster-randomized controlled trial from a societal perspective. Participants received care as usual (n = 140) or Step-Dep (n = 96) which consisted of four sequential treatment steps: watchful waiting, guided self-help, problem solving treatment and referral to a general practitioner. Primary outcomes were quality-adjusted life years (QALYs) and cumulative incidence of major depression. Costs were measured every 3 months. Missing data was imputed using multiple imputation. Uncertainty around cost-effectiveness outcomes was estimated using bootstrapping and presented in cost-effectiveness planes and acceptability curves. RESULTS There were no significant differences in QALYs or depression incidence between treatment groups. Secondary care costs (mean difference €1644, 95% CI €344; €3370) and informal care costs (mean difference €1930, 95% CI €528; €4089) were significantly higher in the Step-Dep group than in the usual care group. The difference in total societal costs (€1001, 95% CI €-3975; €6409) was not statistically significant. The probability of the Step-Dep intervention being cost-effective was low, with a maximum of 0.41 at a ceiling ratio of €30,000 per QALY gained and 0.32 at a ceiling ratio of €0 per prevented case of major depression. CONCLUSIONS The Step-Dep intervention is not cost-effective compared to usual care in a population of patients with DM2/CHD and subthreshold depression. Therefore, widespread implementation cannot be recommended. TRIAL REGISTRATION The trial was registered in the Netherlands Trial Register ( NTR3715 ).
Collapse
Affiliation(s)
- S. E. M. van Dijk
- grid.16872.3a0000 0004 0435 165XDepartment of Health Sciences, Faculty of Science, Vrije Universiteit Amsterdam, Amsterdam Public Health research institute, De Boelelaan 1085, 1081 HV Amsterdam, the Netherlands
| | - A. D. Pols
- grid.16872.3a0000 0004 0435 165XDepartment of Health Sciences, Faculty of Science, Vrije Universiteit Amsterdam, Amsterdam Public Health research institute, De Boelelaan 1085, 1081 HV Amsterdam, the Netherlands ,grid.16872.3a0000 0004 0435 165XDepartment of General Practice and Elderly Medicine and the Amsterdam Public Health research institute, VU University Medical Centre, Amsterdam, The Netherlands
| | - M. C. Adriaanse
- grid.16872.3a0000 0004 0435 165XDepartment of Health Sciences, Faculty of Science, Vrije Universiteit Amsterdam, Amsterdam Public Health research institute, De Boelelaan 1085, 1081 HV Amsterdam, the Netherlands
| | - H. W. J. van Marwijk
- grid.16872.3a0000 0004 0435 165XDepartment of General Practice and Elderly Medicine and the Amsterdam Public Health research institute, VU University Medical Centre, Amsterdam, The Netherlands ,Department of Primary Care and Public Health Medicine, Brighton, UK ,Sussex Medical School, Brighton, UK
| | - M. W. van Tulder
- grid.16872.3a0000 0004 0435 165XDepartment of Health Sciences, Faculty of Science, Vrije Universiteit Amsterdam, Amsterdam Public Health research institute, De Boelelaan 1085, 1081 HV Amsterdam, the Netherlands
| | - J. E. Bosmans
- grid.16872.3a0000 0004 0435 165XDepartment of Health Sciences, Faculty of Science, Vrije Universiteit Amsterdam, Amsterdam Public Health research institute, De Boelelaan 1085, 1081 HV Amsterdam, the Netherlands
| |
Collapse
|
4
|
Gramaglia C, Gattoni E, Marangon D, Concina D, Grossini E, Rinaldi C, Panella M, Zeppegno P. Non-pharmacological Approaches to Depressed Elderly With No or Mild Cognitive Impairment in Long-Term Care Facilities. A Systematic Review of the Literature. Front Public Health 2021; 9:685860. [PMID: 34336772 PMCID: PMC8322575 DOI: 10.3389/fpubh.2021.685860] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/26/2021] [Accepted: 06/17/2021] [Indexed: 11/24/2022] Open
Abstract
Introduction: Compared to old people who live at home, depressive symptoms are more prevalent in those who live in long-term care facilities (LTCFs). Different kinds of non-pharmacological treatment approaches in LTCFs have been studied, including behavioral and cognitive-behavioral therapy, cognitive bibliotherapy, problem-solving therapy, brief psychodynamic therapy and life review/reminiscence. The aim of the current review was to systematically review non-pharmacological treatments used to treat depressed older adults with no or mild cognitive impairment (as described by a Mini Mental State Examination score > 20) living in LTCFs. Methods: A research was performed on PubMed and Scopus databases. Following the Preferred Reporting Items for Systematic Reviews and MetaAnalyses (PRISMA) flowchart, studies selection was made. The quality of each Randomized Controlled Trial was scored using the Jadad scale, Quasi-Experimental Design studies and Non-Experimental studies were scored based on the Newcastle-Ottawa Scale (NOS) Results: The review included 56 full text articles; according to the type of intervention, studies were grouped in the following areas: horticulture/gardening (n = 3), pet therapy (n = 4), physical exercise (n = 9), psychoeducation/rehabilitation (n = 15), psychotherapy (n = 3), reminiscence and story sharing (n = 14), miscellaneous (n = 8). Discussion and Conclusion: Despite mixed or negative findings in some cases, most studies included in this systematic review reported that the non-pharmacological interventions assessed were effective in the management of depressed elderly in the LTCFs context. Regrettably, the limitations and heterogeneity of the studies described above hinder the possibility to generalize and replicate results.
Collapse
Affiliation(s)
- Carla Gramaglia
- Department of Translational Medicine (DIMET), Università del Piemonte Orientale, Novara, Italy
- Psychiatry Ward, Maggiore della Carità University Hospital, Novara, Italy
| | - Eleonora Gattoni
- Psychiatry Ward, Maggiore della Carità University Hospital, Novara, Italy
| | - Debora Marangon
- Psychiatry Ward, Maggiore della Carità University Hospital, Novara, Italy
| | - Diego Concina
- Department of Translational Medicine (DIMET), Università del Piemonte Orientale, Novara, Italy
| | - Elena Grossini
- Department of Translational Medicine (DIMET), Università del Piemonte Orientale, Novara, Italy
| | - Carmela Rinaldi
- Department of Translational Medicine (DIMET), Università del Piemonte Orientale, Novara, Italy
| | - Massimiliano Panella
- Department of Translational Medicine (DIMET), Università del Piemonte Orientale, Novara, Italy
| | - Patrizia Zeppegno
- Department of Translational Medicine (DIMET), Università del Piemonte Orientale, Novara, Italy
- Psychiatry Ward, Maggiore della Carità University Hospital, Novara, Italy
| |
Collapse
|
5
|
Health-economic evaluation of psychological interventions for depression prevention: Systematic review. Clin Psychol Rev 2021; 88:102064. [PMID: 34304111 DOI: 10.1016/j.cpr.2021.102064] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/18/2020] [Revised: 06/24/2021] [Accepted: 06/30/2021] [Indexed: 01/03/2023]
Abstract
Psychological interventions have been proven to be effective to prevent depression, however, little is known on the cost-effectiveness of psychological interventions for the prevention of depression in various populations. A systematic review was conducted using PubMed, PsycINFO, Web of Science, Embase, Cochrane Central Register of Controlled Trials, Econlit, NHS Economic Evaluations Database, NHS Health Technology Assessment and OpenGrey up to January 2021. Only health-economic evaluations based on randomized controlled trials of psychological interventions to prevent depression were included. Independent evaluators selected studies, extracted data and assessed the quality using the Consensus on Health Economic Criteria and the Cochrane Risk of Bias Tool. Twelve trial-based economic evaluations including 5929 participants from six different countries met the inclusion criteria. Overall, the quality of most economic evaluations was considered good, but some studies have some risk of bias. Setting the willingness-to-pay upper limit to US$40,000 (2018 prices) for gaining one quality adjusted life year (QALY), eight psychological preventive interventions were likely to be cost-effective compared to care as usual. The likelihood of preventive psychological interventions being more cost-effective than care as usual looks promising, but more economic evaluations are needed to bridge the many gaps that remain in the evidence-base. ETHICS: As this systematic review is based on published data, approval from the local ethics committee was not required.
Collapse
|
6
|
Le LKD, Esturas AC, Mihalopoulos C, Chiotelis O, Bucholc J, Chatterton ML, Engel L. Cost-effectiveness evidence of mental health prevention and promotion interventions: A systematic review of economic evaluations. PLoS Med 2021; 18:e1003606. [PMID: 33974641 PMCID: PMC8148329 DOI: 10.1371/journal.pmed.1003606] [Citation(s) in RCA: 43] [Impact Index Per Article: 14.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/21/2020] [Revised: 05/25/2021] [Accepted: 03/31/2021] [Indexed: 11/21/2022] Open
Abstract
BACKGROUND The prevention of mental disorders and promotion of mental health and well-being are growing fields. Whether mental health promotion and prevention interventions provide value for money in children, adolescents, adults, and older adults is unclear. The aim of the current study is to update 2 existing reviews of cost-effectiveness studies in this field in order to determine whether such interventions are cost-effective. METHODS AND FINDINGS Electronic databases (including MEDLINE, PsycINFO, CINAHL, and EconLit through EBSCO and Embase) were searched for published cost-effectiveness studies of prevention of mental disorders and promotion of mental health and well-being from 2008 to 2020. The quality of studies was assessed using the Quality of Health Economic Studies Instrument (QHES). The protocol was registered with PROSPERO (# CRD42019127778). The primary outcomes were incremental cost-effectiveness ratio (ICER) or return on investment (ROI) ratio across all studies. A total of 65 studies met the inclusion criteria of a full economic evaluation, of which, 23 targeted children and adolescents, 35 targeted adults, while the remaining targeted older adults. A large number of studies focused on prevention of depression and/or anxiety disorders, followed by promotion of mental health and well-being and other mental disorders. Although there was high heterogeneity in terms of the design among included economic evaluations, most studies consistently found that interventions for mental health prevention and promotion were cost-effective or cost saving. The review found that targeted prevention was likely to be cost-effective compared to universal prevention. Screening plus psychological interventions (e.g., cognitive behavioural therapy [CBT]) at school were the most cost-effective interventions for prevention of mental disorders in children and adolescents, while parenting interventions and workplace interventions had good evidence in mental health promotion. There is inconclusive evidence for preventive interventions for mental disorders or mental health promotion in older adults. While studies were of general high quality, there was limited evidence available from low- and middle-income countries. The review was limited to studies where mental health was the primary outcome and may have missed general health promoting strategies that could also prevent mental disorder or promote mental health. Some ROI studies might not be included given that these studies are commonly published in grey literature rather than in the academic literature. CONCLUSIONS Our review found a significant growth of economic evaluations in prevention of mental disorders or promotion of mental health and well-being over the last 10 years. Although several interventions for mental health prevention and promotion provide good value for money, the varied quality as well as methodologies used in economic evaluations limit the generalisability of conclusions about cost-effectiveness. However, the finding that the majority of studies especially in children, adolescents, and adults demonstrated good value for money is promising. Research on cost-effectiveness in low-middle income settings is required. TRIAL REGISTRATION PROSPERO registration number: CRD42019127778.
Collapse
Affiliation(s)
- Long Khanh-Dao Le
- Deakin University, Deakin Health Economics, Institute for Health Transformation, School of Health and Social Development, Geelong, Australia
- * E-mail:
| | - Adrian Cuevas Esturas
- Deakin University, Deakin Health Economics, Institute for Health Transformation, School of Health and Social Development, Geelong, Australia
| | - Cathrine Mihalopoulos
- Deakin University, Deakin Health Economics, Institute for Health Transformation, School of Health and Social Development, Geelong, Australia
| | - Oxana Chiotelis
- Deakin University, Deakin Health Economics, Institute for Health Transformation, School of Health and Social Development, Geelong, Australia
| | - Jessica Bucholc
- Deakin University, Deakin Health Economics, Institute for Health Transformation, School of Health and Social Development, Geelong, Australia
| | - Mary Lou Chatterton
- Deakin University, Deakin Health Economics, Institute for Health Transformation, School of Health and Social Development, Geelong, Australia
| | - Lidia Engel
- Deakin University, Deakin Health Economics, Institute for Health Transformation, School of Health and Social Development, Geelong, Australia
| |
Collapse
|
7
|
Translating evidence-based psychological interventions for older adults with depression and anxiety into public and private mental health settings using a stepped care framework: Study protocol. Contemp Clin Trials 2021; 104:106360. [PMID: 33766760 DOI: 10.1016/j.cct.2021.106360] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/04/2020] [Revised: 03/10/2021] [Accepted: 03/11/2021] [Indexed: 11/23/2022]
Abstract
BACKGROUND With expected increases in the number of older adults worldwide, the delivery of stepped psychological care for depression and anxiety in older populations may improve both treatment and allocative efficiency for individual patients and the health system. DESIGN A multisite pragmatic randomised controlled trial evaluating the clinical and cost-effectiveness of a stepped care model of care for treating depression and anxiety among older adults compared to treatment as usual (TAU) will be conducted. Eligible participants (n = 666) with clinically interfering anxiety and/or depression symptoms will be recruited from and treated within six Australian mental health services. The intervention group will complete a low intensity cognitive behavioural therapy (CBT) program: Internet-delivered or using a work-at-home book with brief therapist calls (STEP 1). Following STEP 1 a higher intensity face-to-face CBT (STEP 2) will then be offered if needed. Intention-to-treat analyses will be used to examine changes in primary outcomes (e.g. clinician-rated symptom severity changes) and secondary outcomes (e.g. self-reported symptoms severity, health related quality of life and service utilisation costs). An economic evaluation will be conducted using a cost-utility analysis to derive the incremental cost-effectiveness ratio for the stepped care intervention. DISCUSSION This study will demonstrate the relative clinical and economic benefits of stepped care model of psychological care for older adults experiencing anxiety and/or depression compared to TAU. The evaluation of the intervention within existing mental health services means that results will have significant implications for the translation of evidence-based interventions in older adult services across urban and rural settings. TRAIL REGISTRATION Prospectively registered on anzctr.org.au (ACTRN12619000219189) and isrctn.com (ISRCTN37503850).
Collapse
|
8
|
Economic Evaluations of Public Health Interventions to Improve Mental Health and Prevent Suicidal Thoughts and Behaviours: A Systematic Literature Review. ADMINISTRATION AND POLICY IN MENTAL HEALTH AND MENTAL HEALTH SERVICES RESEARCH 2020; 48:299-315. [PMID: 32734522 PMCID: PMC7870636 DOI: 10.1007/s10488-020-01072-9] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/10/2023]
Abstract
To review the literature on economic evaluations of public health interventions targeting prevention of mental health problems and suicide, to support evidence based societal resource allocation. A systematic review of economic evaluations within mental health and suicide prevention was conducted including studies published between January 2000 and November 2018. The studies were identified through Medline, PsychINFO, Web of Science, the National Health Service Economic Evaluation Database and Health Technology Assessment. The quality of relevant studies and the transferability of their results were assessed using a criterion set out by the Swedish Agency for Health Technology Assessment. Nineteen studies of moderate to high quality were included in this review, which evaluated 18 interventions in mental health and four interventions in suicide prevention. Fourteen (63%) of all interventions were cost-effective based on the conclusions from original papers. None of the studies that evaluated suicide prevention was of high quality. The interventions largely focused on psychological interventions at school, the workplace and within elderly care as well as screening and brief interventions in primary care. Nine studies (around 50% of included articles) had a high potential for transferability to the Swedish context. Public health interventions aiming to improve mental health have a high potential to be economically beneficial to society, but high-quality evidence on the cost-effectiveness of suicide prevention is limited.
Collapse
|
9
|
Gleeson H, Hafford-Letchfield T, Quaife M, Collins DA, Flynn A. Preventing and responding to depression, self-harm, and suicide in older people living in long term care settings: a systematic review. Aging Ment Health 2019; 23:1467-1477. [PMID: 30392380 DOI: 10.1080/13607863.2018.1501666] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Abstract
Objective: The well documented demographic shift to an aging population means that more people will in future be in need of long term residential care. Previous research has reported an increased risk of mental health issues and suicidal ideation among older people living in residential care settings. However, there is little information on the actual prevalence of depression, self-harm, and suicidal behavior in this population, how it is measured and how care homes respond to these issues. Method: This systematic review of international literature addressed three research questions relating to; the prevalence of mental health problems in this population; how they are identified and; how care homes try to prevent or respond to mental health issues. Results: Findings showed higher reported rates of depression and suicidal behavior in care home residents compared to matched age groups in the community, variation in the use of standardised measures across studies and, interventions almost exclusively focused on increasing staff knowledge about mental health but with an absence of involvement of older people themselves in these programmes. Conclusion: We discuss the implications of these findings in the context of addressing mental health difficulties experienced by older people in residential care and future research in this area.
Collapse
Affiliation(s)
- Helen Gleeson
- Department of Mental Health, Social Work & Interprofessional Learning, School of Health and Education, Room T304, Middlesex University , London
| | - Trish Hafford-Letchfield
- Professor of Social Care, Department of Mental Health, Social Work, Interprofessional Learning and Integrative Medicine School of Health and Education Middlesex University , London , UK
| | - Matthew Quaife
- Department of Mental Health, Social Work & Interprofessional Learning, School of Health & Education, Middlesex University , London , UK
| | - Daniela A Collins
- Director of Programmes Mental Health, Department of Mental Health, Social Work & Interprofessional Learning, School of Health and Education, Middlesex University , London , UK
| | - Ann Flynn
- Staff Tutor and Locality Lead (London & South East), Open University London and the South East, Faculty of Wellbeing, Education and Language Studies, School of Health, Wellbeing and Social Care , Milton Keynes , UK
| |
Collapse
|
10
|
Adriaenssens J, Benahmed N, Ricour C. Improving mental healthcare for the elderly in Belgium. Int J Health Plann Manage 2019; 34:e1948-e1960. [PMID: 31347202 DOI: 10.1002/hpm.2858] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/16/2019] [Revised: 06/06/2019] [Accepted: 07/09/2019] [Indexed: 11/07/2022] Open
Abstract
INTRODUCTION The organisation of mental healthcare for the elderly (MHCE) remains suboptimal. OBJECTIVE To identify specific organisational models that could address the mental healthcare needs of the elderly in community and primary care. METHOD A multi-modal approach, consisting of a literature review, an online survey of Belgian professional stakeholders, and an international comparison. The outcomes of this three-step study process were aggregated. RESULTS Two general and four operational strategies for organising MHCE were identified as well as barriers and incentives to MHCE in the community and primary care. About half of survey respondents perceived the current MHCE in Belgium not to meet quality criteria as described in the literature and proposed points of improvement. The transversal international comparison revealed interesting approaches for MHCE. Recommendations for the future were formulated. CONCLUSION MHCE requires a specific, low-threshold, holistic, and transdisciplinary approach. Specific strategies with emphasis on collaborative care should be applied to meet the needs of older adults with mental problems. General practitioners (GPs) can play a central role in community-oriented MHCE but should be supported by specialised healthcare providers (including old-age psychiatrists and geriatricians). Stigma and wrong beliefs, regarding the elderly population, should be tackled by means of campaigns.
Collapse
Affiliation(s)
| | | | - Céline Ricour
- Belgian Health Care Knowledge Centre, Brussels, Belgium
| |
Collapse
|
11
|
Michel L, Conq E, Combs E, Cholet J, Bodenez P, Le Reste JY, Landreat MG. Alcohol use by people in their seventies is not an exception: a preliminary prospective study. Br J Community Nurs 2019; 24:128-133. [PMID: 30817203 DOI: 10.12968/bjcn.2019.24.3.128] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
The ageing population is rapidly increasing worldwide, and the alcohol-related disease burden in most Western countries is on the rise. However, very few studies assess alcohol use in older people. Here, a self-reported questionnaire was administered to all individuals aged 70 years or more who visited a social centre for older people in western France. The average age of the 98 subjects included in the survey was 79 years (range, 70-97 years; SD=6), and 57.1% (n=56) reported weekly alcohol consumption. An average consumption of over two standard units each day during weekends was reported by 53% subjects (n=52), and the same on each weekday was reported by 34% (n=33). Thus, a significant proportion of subjects aged 70 years or over consumed more alcohol than is recommended in current guidelines. The participants also reported that they rarely discussed alcohol consumption with their general practitioners. Alcohol use should be assessed regularly. District nurses and members of the primary care team should recommend strategies to help older people reduce their alcohol consumption.
Collapse
Affiliation(s)
- Lenaig Michel
- Specialised Nurse, Addictive Disorders Unit, University Hospital of Brest, Brest, France
| | - Estelle Conq
- EA Soins primaires, Santé publique, Registre des cancers de Bretagne Occidentale (SPURBO), Family Practice Department, Université Bretagne Occidentale, Brest, France
| | | | - Jennyfer Cholet
- Addictive Disorders Unit, University Hospital of Nantes, Nantes, France
| | - Pierre Bodenez
- EA SPURBO, Université Bretagne Occidentale, Brest, France
| | | | | |
Collapse
|
12
|
Grochtdreis T, Brettschneider C, Bjerregaard F, Bleich C, Boczor S, Härter M, Hölzel LP, Hüll M, Kloppe T, Niebling W, Scherer M, Tinsel I, König HH. Cost-effectiveness analysis of collaborative treatment of late-life depression in primary care (GermanIMPACT). Eur Psychiatry 2019; 57:10-18. [PMID: 30658275 DOI: 10.1016/j.eurpsy.2018.12.007] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/04/2018] [Revised: 12/11/2018] [Accepted: 12/13/2018] [Indexed: 10/27/2022] Open
Abstract
BACKGROUND Late-life depression is a highly prevalent disorder that causes a large economic burden. A stepped collaborative care program was set up in order to improve care for patients with late-life depression in primary care in Germany: GermanIMPACT is the adaption of the Improving Mood-Promoting Access to Collaborative Treatment (IMPACT) program that has already been established in primary care in the USA. The aim of this study was to determine the cost-effectiveness of GermanIMPACT compared with treatment as usual from a societal perspective. METHODS This study is part of a 12-month bi-centric cluster-randomized controlled trial aiming to assess the effectiveness of GermanIMPACT compared with treatment as usual among patients with late-life depression. A cost-effectiveness analysis using depression-free days (DFDs) was performed. Net-monetary benefit (NMB) regressions adjusted for baseline differences for different willingness-to-pay (WTP) thresholds were conducted and cost-effectiveness acceptability curves were constructed. RESULTS In total, n = 246 patients (intervention group: n = 139; control group: n = 107) with a mean age of 71 from 71 primary care practices were included in the analysis. After 12 months, adjusted mean differences in costs and DFDs between intervention group and control group were +€354 and +21.4, respectively. Only the difference in DFDs was significant (p = 0.022). According to the unadjusted incremental cost-effectiveness ratio, GermanIMPACT was dominant compared with treatment as usual. The probability of GermanIMPACT being cost-effective was 80%, 90% or 95% if societal WTP per DFD was ≥€70, ≥€110 or ≥€180, respectively. CONCLUSION Evidence for cost-effectiveness of GermanIMPACT relative to treatment as usual is not clear. Only if societal WTP was ≥€180 for an additional DFD, GermanIMPACT could be considered cost-effective with certainty.
Collapse
Affiliation(s)
- Thomas Grochtdreis
- Department of Health Economics and Health Services Research, Hamburg Center for Health Economics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
| | - Christian Brettschneider
- Department of Health Economics and Health Services Research, Hamburg Center for Health Economics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| | - Frederike Bjerregaard
- Department of Psychiatry and Psychotherapy, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
| | - Christiane Bleich
- Department of Medical Psychology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| | - Sigrid Boczor
- Department of General Practice / Primary Care, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| | - Martin Härter
- Department of Medical Psychology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| | - Lars P Hölzel
- Department of Psychiatry and Psychotherapy, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; Parkklinik Wiesbaden Schlangenbad, Schlangenbad, Germany
| | - Michael Hüll
- Center for Psychiatry Emmendingen, Emmendingen, Germany; Center for Geriatric Medicine and Gerontology, Medical Center - University of Freiburg, Faculty of Medicine, Freiburg, Germany
| | - Thomas Kloppe
- Department of General Practice / Primary Care, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| | - Wilhelm Niebling
- Division of General Practice, Medical Center - University of Freiburg, Faculty of Medicine, Freiburg, Germany
| | - Martin Scherer
- Department of General Practice / Primary Care, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| | - Iris Tinsel
- Division of General Practice, Medical Center - University of Freiburg, Faculty of Medicine, Freiburg, Germany
| | - Hans-Helmut König
- Department of Health Economics and Health Services Research, Hamburg Center for Health Economics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| |
Collapse
|
13
|
The assessment of anxiety in aged care residents: a systematic review of the psychometric properties of commonly used measures. Int Psychogeriatr 2018; 30:967-979. [PMID: 29223175 DOI: 10.1017/s1041610217002599] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
UNLABELLED ABSTRACTBackground:Assessing anxiety among residential aged care facility (RACF) residents is challenging, and it cannot be assumed that valid and reliable measures used within the community are also appropriate for this setting. This review systematically examined the literature to identify which anxiety measures were most commonly used with older adults in RACFs, and determine whether psychometric data support their use within this population. METHODS Using the PRISMA guidelines, five electronic databases were searched using key terms and subject headings. The search was limited to literature published in English. Eligible studies utilized an anxiety measure to assess anxiety symptoms among RACF residents. Based on the findings of this search, a critical review of the research into the reliability, validity, and administrative and respondent burden of the most commonly used measures (i.e. used in four or more studies) was conducted. RESULTS In total, 1,771 articles were identified, with 50 studies included in this review. Overall, 22 measures were used, with the majority of studies utilizing a clinician-administered or self-report measure. The RAID, HADS, STAI, and GAI were the most commonly used measures. While overall there is a lack of research and consensus into the psychometric properties of these measures within RACFs, strongest evidence of reliability and validity was found for the GAI. CONCLUSION Commonly used measures of anxiety within aged care populations are not well validated for this complex subsample of older adults. Strengths and weaknesses of each measure with regards to their usefulness in aged care settings are discussed, with future research areas highlighted.
Collapse
|
14
|
Muñoz M, Ausín B, Santos-Olmo AB, Härter M, Volkert J, Schulz H, Sehner S, Dehoust MC, Suling A, Wegscheider K, Canuto A, Crawford MJ, Grassi L, Da Ronch C, Hershkovitz Y, Quirk A, Rotenstein O, Shalev AY, Strehle J, Weber K, Wittchen HU, Andreas S. Alcohol use, abuse and dependence in an older European population: Results from the MentDis_ICF65+ study. PLoS One 2018; 13:e0196574. [PMID: 29708993 PMCID: PMC5927409 DOI: 10.1371/journal.pone.0196574] [Citation(s) in RCA: 20] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/21/2017] [Accepted: 04/16/2018] [Indexed: 11/18/2022] Open
Abstract
BACKGROUND Alcohol use disorders (AUD) in older people have been the subject of increasing interest in Europe and worldwide. However, thus far, no reliable data exist regarding the prevalence of AUD in people over the age of 65 years in Europe. OBJECTIVE To assess the current (past month), 12-month and lifetime prevalence of alcohol use, abuse and dependence in people aged 65-84 years. STUDY DESIGN The MentDis_ICF65+ study was a representative stepwise cross-sectional survey that was conducted in six European and associated cities (Hamburg, Germany; Ferrara, Italy; London/Canterbury, England; Madrid, Spain; Geneva, Switzerland and Jerusalem, Israel). METHOD In total, 3,142 community-dwelling people aged between 65 and 84 years who lived in participating cities were assessed with an age-sensitive diagnostic interview (CIDI65+). RESULTS The prevalence of lifetime alcohol use was 81% for the overall sample. The observed AUD (DSM-IV-TR) prevalence was as follows: current, 1.1%; 12-month, 5.3% and lifetime, 8.8%. Alcohol consumption and AUD were more prevalent in males, and a significant interaction between gender and city was observed; greater gender differences in the prevalence of these disorders were observed in Hamburg, London/Canterbury and Geneva in comparison to the other cities. The prevalence of lifetime alcohol consumption and 12-month AUD tended to be lower in older persons. CONCLUSION The results highlight the appropriateness of using age-adjusted diagnostic tools (CIDI65+) to identify alcohol use and AUD in older people. Different alcohol use patterns were observed in males and females. The results seem to indicate the presence of different alcohol use patterns between northern and southern European countries. Specialized services are proposed, including brief and/or more intensive interventions framed intensive and more simple interventions framed in stepped care strategies, to improve the social and health resources available for older people across Europe.
Collapse
Affiliation(s)
- Manuel Muñoz
- School of Psychology, Complutense University of Madrid, Madrid, Spain
| | - Berta Ausín
- School of Psychology, Complutense University of Madrid, Madrid, Spain
- * E-mail:
| | | | - Martin Härter
- Department of Medical Psychology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| | - Jana Volkert
- Department of Medical Psychology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
- Department of Psychosocial Prevention, University of Heidelberg, Heidelberg, Germany
| | - Holger Schulz
- Department of Medical Psychology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| | - Susanne Sehner
- Institute of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| | - Maria Christina Dehoust
- Department of Medical Psychology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| | - Anna Suling
- Institute of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| | - Karl Wegscheider
- Institute of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| | - Alessandra Canuto
- Nant Foundation, East Vaud Psychiatric Institute, Geneva, Switzerland
| | | | - Luigi Grassi
- Institute of Psychiatry, Dpt. Biomedical and Specialty Surgical Sciences, University of Ferrara, Ferrara, Italy
| | - Chiara Da Ronch
- Institute of Psychiatry, Dpt. Biomedical and Specialty Surgical Sciences, University of Ferrara, Ferrara, Italy
| | - Yael Hershkovitz
- Department of Psychiatry, Hadassah University Medical Center, Jerusalem, Israel
| | - Alan Quirk
- Royal College of Psychiatrist, London, United Kingdom
| | - Ora Rotenstein
- Department of Psychiatry, Hadassah University Medical Center, Jerusalem, Israel
| | - Arieh Y. Shalev
- Department of Psychiatry, NY Langone Medical Center, New York, United States of America
| | - Jens Strehle
- Institute of Clinical Psychology and Psychotherapy, Technische Universitaet Dresden, Dresden, Germany
| | - Kerstin Weber
- Curabilis, Medical Direction, University Hospitals of Geneva, Geneva, Switzerland
| | - Hans-Ulrich Wittchen
- Institute of Clinical Psychology and Psychotherapy, Technische Universitaet Dresden, Dresden, Germany
| | - Sylke Andreas
- Department of Medical Psychology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| |
Collapse
|
15
|
van der Aa HPA, van Rens GHMB, Bosmans JE, Comijs HC, van Nispen RMA. Economic evaluation of stepped-care versus usual care for depression and anxiety in older adults with vision impairment: randomized controlled trial. BMC Psychiatry 2017; 17:280. [PMID: 28764679 PMCID: PMC5539614 DOI: 10.1186/s12888-017-1437-5] [Citation(s) in RCA: 21] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/06/2016] [Accepted: 07/20/2017] [Indexed: 11/22/2022] Open
Abstract
BACKGROUND A stepped-care program was found effective in preventing depressive and anxiety disorders in older adults with vision impairment. However, before a decision can be made about implementation, the cost-effectiveness of this program should be investigated. Therefore, we aimed to compare the cost-effectiveness of stepped-care versus usual care within low vision rehabilitation. METHODS An economic evaluation from a societal perspective was performed alongside a multicenter randomized controlled trial. Data were collected by masked assessors during 24 months. Included were 265 older adults with vision impairment and subthreshold depression and/or anxiety. They were randomly assigned to stepped-care plus usual care (n = 131) or usual care alone (n = 134). Stepped-care comprised 1) watchful waiting, 2) guided self-help based on cognitive behavioral therapy, 3) problem solving treatment, and 4) referral to a general practitioner. Costs were based on direct healthcare costs and indirect non-healthcare costs. Main outcome measures were quality-adjusted life years (QALYs) and the cumulative incidence of major depressive, dysthymic and/or anxiety disorders. Secondary outcomes were symptoms of depression and anxiety. RESULTS Based on intention-to-treat, significant differences were found in the incidence of depressive/anxiety disorders (mean difference 0.17; 95% CI 0.06 to 0.29) and symptoms of anxiety (mean difference 1.43, 95% CI 0.10 to 2.77) in favor of stepped-care versus usual care; no significant difference was found for QALYs and symptoms of depression. Societal costs were non-significantly lower in the stepped-care group compared with the usual care group (mean difference: -€877; 95% confidence interval (CI): -8039 to 5489). Cost-effectiveness acceptability curves showed that the probability of cost-effectiveness was 95% or more at a willingness-to-pay of €33,000 per disorder prevented. The probability that stepped-care was cost-effective compared to usual care was 59% or more for a ceiling ratio of 0 €/QALY and increased to 65% at 20000 €/QALY. CONCLUSIONS This economic evaluation shows that stepped-care is dominant to usual care, with a probability of around 60%, due to its clinical superiority and its modest cost savings. However, it depends on the willingness-to-pay of decision makers whether or not stepped-care is considered cost-effective compared with usual care. TRIAL REGISTRATION identifier: NTR3296 , date: 13-02-2012.
Collapse
Affiliation(s)
- Hilde P. A. van der Aa
- 0000 0004 0435 165Xgrid.16872.3aDepartment of Ophthalmology and the Amsterdam Public Health Research Institute, VU University Medical Centre, De Boelelaan 1117, 1081 Amsterdam, HV The Netherlands
| | - Ger H. M. B. van Rens
- 0000 0004 0435 165Xgrid.16872.3aDepartment of Ophthalmology and the Amsterdam Public Health Research Institute, VU University Medical Centre, De Boelelaan 1117, 1081 Amsterdam, HV The Netherlands ,0000 0004 0409 6003grid.414480.dDepartment of Ophthalmology, Elkerliek Hospital, Wesselmanlaan 25, 5707 Helmond, HA The Netherlands
| | - Judith E. Bosmans
- 0000 0004 1754 9227grid.12380.38Department of Health Sciences and the Amsterdam Public Health Research Institute, Faculty of Earth and Life Sciences, VU University Amsterdam, De Boelelaan 1105, 1081 Amsterdam, HV The Netherlands
| | - Hannie C. Comijs
- Department of Psychiatry VUmc/GGZinGeest, A.J.Ernststraat 1187, 1081 Amsterdam, HL The Netherlands
| | - Ruth M. A. van Nispen
- 0000 0004 0435 165Xgrid.16872.3aDepartment of Ophthalmology and the Amsterdam Public Health Research Institute, VU University Medical Centre, De Boelelaan 1117, 1081 Amsterdam, HV The Netherlands
| |
Collapse
|
16
|
Kolovos S, Bosmans JE, van Dongen JM, van Esveld B, Magai D, van Straten A, van der Feltz-Cornelis C, van Steenbergen-Weijenburg KM, Huijbregts KM, van Marwijk H, Riper H, van Tulder MW. Utility scores for different health states related to depression: individual participant data analysis. Qual Life Res 2017; 26:1649-1658. [PMID: 28260149 PMCID: PMC5486895 DOI: 10.1007/s11136-017-1536-2] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 02/21/2017] [Indexed: 01/30/2023]
Abstract
OBJECTIVES Depression is associated with considerable impairments in health-related quality-of-life. However, the relationship between different health states related to depression severity and utility scores is unclear. The aim of this study was to evaluate whether utility scores are different for various health states related to depression severity. METHODS We gathered individual participant data from ten randomized controlled trials evaluating depression treatments. The UK EQ-5D and SF-6D tariffs were used to generate utility scores. We defined five health states that were proposed from American Psychiatric Association and National Institute for Clinical Excellence guidelines: remission, minor depression, mild depression, moderate depression, and severe depression. We performed multilevel linear regression analysis. RESULTS We included 1629 participants in the analyses. The average EQ-5D utility scores for the five health states were 0.70 (95% CI 0.67-0.73) for remission, 0.62 (95% CI 0.58-0.65) for minor depression, 0.57 (95% CI 0.54-0.61) for mild depression, 0.52 (95%CI 0.49-0.56) for moderate depression, and 0.39 (95% CI 0.35-0.43) for severe depression. In comparison with the EQ-5D, the utility scores based on the SF-6D were similar for remission (EQ-5D = 0.70 vs. SF-6D = 0.69), but higher for severe depression (EQ-5D = 0.39 vs. SF-6D = 0.55). CONCLUSIONS We observed statistically significant differences in utility scores between depression health states. Individuals with less severe depressive symptoms had on average statistically significant higher utility scores than individuals suffering from more severe depressive symptomatology. In the present study, EQ-5D had a larger range of values as compared to SF-6D.
Collapse
Affiliation(s)
- Spyros Kolovos
- Department of Health Sciences, and the EMGO Institute for Health and Care Research, Faculty of Earth and Life Sciences, VU University Amsterdam, De Boelelaan 1085, 1081 HV, Amsterdam, The Netherlands.
| | - Judith E Bosmans
- Department of Health Sciences, and the EMGO Institute for Health and Care Research, Faculty of Earth and Life Sciences, VU University Amsterdam, De Boelelaan 1085, 1081 HV, Amsterdam, The Netherlands
| | - Johanna M van Dongen
- Department of Health Sciences, and the EMGO Institute for Health and Care Research, Faculty of Earth and Life Sciences, VU University Amsterdam, De Boelelaan 1085, 1081 HV, Amsterdam, The Netherlands
| | - Birre van Esveld
- Department of Health Sciences, and the EMGO Institute for Health and Care Research, Faculty of Earth and Life Sciences, VU University Amsterdam, De Boelelaan 1085, 1081 HV, Amsterdam, The Netherlands
| | - Dorcas Magai
- Department of Clinical, Neuro and Developmental Psychology, and the EMGO Institute for Health and Care Research, Faculty of Behavioural and Movement Sciences, VU University Amsterdam, Amsterdam, The Netherlands
| | - Annemieke van Straten
- Department of Clinical, Neuro and Developmental Psychology, and the EMGO Institute for Health and Care Research, Faculty of Behavioural and Movement Sciences, VU University Amsterdam, Amsterdam, The Netherlands
| | - Christina van der Feltz-Cornelis
- Department of Social Psychiatry Tranzo, Tilburg University, Tilburg, The Netherlands
- Clinical Centre of Excellence for Body, Mind and Health, GGz Breburg, Tilburg, The Netherlands
| | | | | | - Harm van Marwijk
- Centre for Primary Care, Institute for Population Health, University of Manchester, Manchester, UK
- Department of General Practice and Elderly Care Medicine, VU University Medical Centre, Amsterdam, The Netherlands
| | - Heleen Riper
- Department of Clinical, Neuro and Developmental Psychology, and the EMGO Institute for Health and Care Research, Faculty of Behavioural and Movement Sciences, VU University Amsterdam, Amsterdam, The Netherlands
| | - Maurits W van Tulder
- Department of Health Sciences, and the EMGO Institute for Health and Care Research, Faculty of Earth and Life Sciences, VU University Amsterdam, De Boelelaan 1085, 1081 HV, Amsterdam, The Netherlands
| |
Collapse
|
17
|
Jansen F, Krebber AMH, Coupé VMH, Cuijpers P, de Bree R, Becker-Commissaris A, Smit EF, van Straten A, Eeckhout GM, Beekman ATF, Leemans CR, Verdonck-de Leeuw IM. Cost-Utility of Stepped Care Targeting Psychological Distress in Patients With Head and Neck or Lung Cancer. J Clin Oncol 2016; 35:314-324. [PMID: 27918712 DOI: 10.1200/jco.2016.68.8739] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023] Open
Abstract
Purpose A stepped care (SC) program in which an effective yet least resource-intensive treatment is delivered to patients first and followed, when necessary, by more resource-intensive treatments was found to be effective in improving distress levels of patients with head and neck cancer or lung cancer. Information on the value of this program for its cost is now called for. Therefore, this study aimed to assess the cost-utility of the SC program compared with care-as-usual (CAU) in patients with head and neck cancer or lung cancer who have psychological distress. Patients and Methods In total, 156 patients were randomly assigned to SC or CAU. Intervention costs, direct medical costs, direct nonmedical costs, productivity losses, and health-related quality-of-life data during the intervention or control period and 12 months of follow-up were calculated by using Trimbos and Institute of Medical Technology Assessment Cost Questionnaire for Psychiatry, Productivity and Disease Questionnaire, and EuroQol-5 Dimension measures and data from the hospital information system. The SC program's value for the cost was investigated by comparing mean cumulative costs and quality-adjusted life years (QALYs). Results After imputation of missing data, mean cumulative costs were -€3,950 (95% CI, -€8,158 to -€190) lower, and mean number of QALYs was 0.116 (95% CI, 0.005 to 0.227) higher in the intervention group compared with the control group. The intervention group had a probability of 96% that cumulative QALYs were higher and cumulative costs were lower than in the control group. Four additional analyses were conducted to assess the robustness of this finding, and they found that the intervention group had a probability of 84% to 98% that cumulative QALYs were higher and a probability of 91% to 99% that costs were lower than in the control group. Conclusion SC is highly likely to be cost-effective; the number of QALYs was higher and cumulative costs were lower for SC compared with CAU.
Collapse
Affiliation(s)
- Femke Jansen
- Femke Jansen, Anna M.H. Krebber, Veerle M.H. Coupé, Annemarie Becker-Commissaris, Egbert F. Smit, Guus M. Eeckhout, Aartjan T.F. Beekman, C. René Leemans, and Irma M. Verdonck-de Leeuw, VU Medical Center; Pim Cuijpers, Annemieke van Straten, and Irma M. Verdonck-de Leeuw, Vrije Universiteit Amsterdam, Amsterdam; and Remco de Bree, University Medical Center Utrecht Cancer Center, Utrecht, Netherlands
| | - Anna M H Krebber
- Femke Jansen, Anna M.H. Krebber, Veerle M.H. Coupé, Annemarie Becker-Commissaris, Egbert F. Smit, Guus M. Eeckhout, Aartjan T.F. Beekman, C. René Leemans, and Irma M. Verdonck-de Leeuw, VU Medical Center; Pim Cuijpers, Annemieke van Straten, and Irma M. Verdonck-de Leeuw, Vrije Universiteit Amsterdam, Amsterdam; and Remco de Bree, University Medical Center Utrecht Cancer Center, Utrecht, Netherlands
| | - Veerle M H Coupé
- Femke Jansen, Anna M.H. Krebber, Veerle M.H. Coupé, Annemarie Becker-Commissaris, Egbert F. Smit, Guus M. Eeckhout, Aartjan T.F. Beekman, C. René Leemans, and Irma M. Verdonck-de Leeuw, VU Medical Center; Pim Cuijpers, Annemieke van Straten, and Irma M. Verdonck-de Leeuw, Vrije Universiteit Amsterdam, Amsterdam; and Remco de Bree, University Medical Center Utrecht Cancer Center, Utrecht, Netherlands
| | - Pim Cuijpers
- Femke Jansen, Anna M.H. Krebber, Veerle M.H. Coupé, Annemarie Becker-Commissaris, Egbert F. Smit, Guus M. Eeckhout, Aartjan T.F. Beekman, C. René Leemans, and Irma M. Verdonck-de Leeuw, VU Medical Center; Pim Cuijpers, Annemieke van Straten, and Irma M. Verdonck-de Leeuw, Vrije Universiteit Amsterdam, Amsterdam; and Remco de Bree, University Medical Center Utrecht Cancer Center, Utrecht, Netherlands
| | - Remco de Bree
- Femke Jansen, Anna M.H. Krebber, Veerle M.H. Coupé, Annemarie Becker-Commissaris, Egbert F. Smit, Guus M. Eeckhout, Aartjan T.F. Beekman, C. René Leemans, and Irma M. Verdonck-de Leeuw, VU Medical Center; Pim Cuijpers, Annemieke van Straten, and Irma M. Verdonck-de Leeuw, Vrije Universiteit Amsterdam, Amsterdam; and Remco de Bree, University Medical Center Utrecht Cancer Center, Utrecht, Netherlands
| | - Annemarie Becker-Commissaris
- Femke Jansen, Anna M.H. Krebber, Veerle M.H. Coupé, Annemarie Becker-Commissaris, Egbert F. Smit, Guus M. Eeckhout, Aartjan T.F. Beekman, C. René Leemans, and Irma M. Verdonck-de Leeuw, VU Medical Center; Pim Cuijpers, Annemieke van Straten, and Irma M. Verdonck-de Leeuw, Vrije Universiteit Amsterdam, Amsterdam; and Remco de Bree, University Medical Center Utrecht Cancer Center, Utrecht, Netherlands
| | - Egbert F Smit
- Femke Jansen, Anna M.H. Krebber, Veerle M.H. Coupé, Annemarie Becker-Commissaris, Egbert F. Smit, Guus M. Eeckhout, Aartjan T.F. Beekman, C. René Leemans, and Irma M. Verdonck-de Leeuw, VU Medical Center; Pim Cuijpers, Annemieke van Straten, and Irma M. Verdonck-de Leeuw, Vrije Universiteit Amsterdam, Amsterdam; and Remco de Bree, University Medical Center Utrecht Cancer Center, Utrecht, Netherlands
| | - Annemieke van Straten
- Femke Jansen, Anna M.H. Krebber, Veerle M.H. Coupé, Annemarie Becker-Commissaris, Egbert F. Smit, Guus M. Eeckhout, Aartjan T.F. Beekman, C. René Leemans, and Irma M. Verdonck-de Leeuw, VU Medical Center; Pim Cuijpers, Annemieke van Straten, and Irma M. Verdonck-de Leeuw, Vrije Universiteit Amsterdam, Amsterdam; and Remco de Bree, University Medical Center Utrecht Cancer Center, Utrecht, Netherlands
| | - Guus M Eeckhout
- Femke Jansen, Anna M.H. Krebber, Veerle M.H. Coupé, Annemarie Becker-Commissaris, Egbert F. Smit, Guus M. Eeckhout, Aartjan T.F. Beekman, C. René Leemans, and Irma M. Verdonck-de Leeuw, VU Medical Center; Pim Cuijpers, Annemieke van Straten, and Irma M. Verdonck-de Leeuw, Vrije Universiteit Amsterdam, Amsterdam; and Remco de Bree, University Medical Center Utrecht Cancer Center, Utrecht, Netherlands
| | - Aartjan T F Beekman
- Femke Jansen, Anna M.H. Krebber, Veerle M.H. Coupé, Annemarie Becker-Commissaris, Egbert F. Smit, Guus M. Eeckhout, Aartjan T.F. Beekman, C. René Leemans, and Irma M. Verdonck-de Leeuw, VU Medical Center; Pim Cuijpers, Annemieke van Straten, and Irma M. Verdonck-de Leeuw, Vrije Universiteit Amsterdam, Amsterdam; and Remco de Bree, University Medical Center Utrecht Cancer Center, Utrecht, Netherlands
| | - C René Leemans
- Femke Jansen, Anna M.H. Krebber, Veerle M.H. Coupé, Annemarie Becker-Commissaris, Egbert F. Smit, Guus M. Eeckhout, Aartjan T.F. Beekman, C. René Leemans, and Irma M. Verdonck-de Leeuw, VU Medical Center; Pim Cuijpers, Annemieke van Straten, and Irma M. Verdonck-de Leeuw, Vrije Universiteit Amsterdam, Amsterdam; and Remco de Bree, University Medical Center Utrecht Cancer Center, Utrecht, Netherlands
| | - Irma M Verdonck-de Leeuw
- Femke Jansen, Anna M.H. Krebber, Veerle M.H. Coupé, Annemarie Becker-Commissaris, Egbert F. Smit, Guus M. Eeckhout, Aartjan T.F. Beekman, C. René Leemans, and Irma M. Verdonck-de Leeuw, VU Medical Center; Pim Cuijpers, Annemieke van Straten, and Irma M. Verdonck-de Leeuw, Vrije Universiteit Amsterdam, Amsterdam; and Remco de Bree, University Medical Center Utrecht Cancer Center, Utrecht, Netherlands
| |
Collapse
|
18
|
The Efficacy and Cost-Effectiveness of Stepped Care Prevention and Treatment for Depressive and/or Anxiety Disorders: A Systematic Review and Meta-Analysis. Sci Rep 2016; 6:29281. [PMID: 27377429 PMCID: PMC4932532 DOI: 10.1038/srep29281] [Citation(s) in RCA: 71] [Impact Index Per Article: 8.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/27/2016] [Accepted: 06/16/2016] [Indexed: 11/22/2022] Open
Abstract
Stepped care is an increasingly popular treatment model for common mental health disorders, given the large discrepancy between the demand and supply of healthcare service available. In this review, we aim to compare the efficacy and cost-effectiveness of stepped care prevention and treatment with care-as-usual (CAU) or waiting-list control for depressive and/or anxiety disorders. 5 databases were utilized from its earliest available records up until April 2015. 10 randomized controlled trials were included in this review, of which 6 examined stepped care prevention and 4 examined stepped care treatment, specifically including ones regarding depressive and/or anxiety disorders. Only trials with self-help as a treatment component were included. Results showed stepped care treatment revealed a significantly better performance than CAU in reducing anxiety symptoms, and the treatment response rate of anxiety disorders was significantly higher in stepped care treatment than in CAU. No significant difference was found between stepped care prevention/treatment and CAU in preventing anxiety and/or depressive disorders and improving depressive symptoms. In conclusion, stepped care model appeared to be better than CAU in treating anxiety disorders. The model has the potential to reduce the burden on existing resources in mental health and increase the reach and availability of service.
Collapse
|
19
|
Joling KJ, Schöpe J, van Hout HPJ, van Marwijk HWJ, van der Horst HE, Bosmans JE. Predictors of Societal Costs in Dementia Patients and Their Informal Caregivers: A Two-Year Prospective Cohort Study. Am J Geriatr Psychiatry 2015; 23:1193-203. [PMID: 26238227 DOI: 10.1016/j.jagp.2015.06.008] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/02/2014] [Revised: 06/03/2015] [Accepted: 06/19/2015] [Indexed: 11/15/2022]
Abstract
OBJECTIVES Dementia poses a substantial economic burden on society. Knowing which factors predict high costs in dementia may help to better target interventions and optimize resource allocation. This study aimed to identify predictors of the total societal costs in dementia patients and their informal caregivers. DESIGN Prospective cohort study with 2-year follow up. SETTING AND PARTICIPANTS 192 community-dwelling patients with dementia and their primary informal caregivers in the Netherlands. MEASUREMENTS Data on health care resource utilization, informal carer time and caregivers' work absenteeism were collected by cost diaries and interviews. Predictors of total costs were identified for patient-caregiver dyads, and for patients and informal caregivers separately by performing univariate and multivariate generalized linear models. RESULTS Societal costs of patient-caregiver dyads averaged €75,084 (SEM: €4,263) in the first year and €99,369 (SEM: €6,441) in the second year. Sixty percent was attributed to costs of informal care. Patient impairments in activities of daily living (ADLs) and instrumental activities of daily living (IADLs), disruptions during daily activities of the caregiver, and receiving case management were significantly associated with higher costs in dyads. The same predictors remained significant for patients' costs separately, and for informal caregivers, a poorer caregiver's quality of life and having more chronic diseases determined higher costs. CONCLUSIONS The societal costs of dementia are substantial and mainly due to high costs of informal care. The burden for caregivers caused by a disrupted schedule and patients' ADL and IADL dependencies contributed most to the total costs. Interventions targeting these factors effectively might result in relevant economic benefits for society.
Collapse
Affiliation(s)
- Karlijn J Joling
- VU University Medical Centre, EMGO+ Institute for Health and Health Care Research, Department of General Practice and Elderly Care Medicine, Amsterdam, The Netherlands.
| | - Jakob Schöpe
- VU University Medical Centre, EMGO+ Institute for Health and Health Care Research, Department of General Practice and Elderly Care Medicine, Amsterdam, The Netherlands
| | - Hein P J van Hout
- VU University Medical Centre, EMGO+ Institute for Health and Health Care Research, Department of General Practice and Elderly Care Medicine, Amsterdam, The Netherlands
| | - Harm W J van Marwijk
- VU University Medical Centre, EMGO+ Institute for Health and Health Care Research, Department of General Practice and Elderly Care Medicine, Amsterdam, The Netherlands
| | - Henriëtte E van der Horst
- VU University Medical Centre, EMGO+ Institute for Health and Health Care Research, Department of General Practice and Elderly Care Medicine, Amsterdam, The Netherlands
| | - Judith E Bosmans
- Faculty of Earth and Life Sciences, VU University Amsterdam, The Netherlands
| |
Collapse
|
20
|
Grochtdreis T, Brettschneider C, Wegener A, Watzke B, Riedel-Heller S, Härter M, König HH. Cost-effectiveness of collaborative care for the treatment of depressive disorders in primary care: a systematic review. PLoS One 2015; 10:e0123078. [PMID: 25993034 PMCID: PMC4437997 DOI: 10.1371/journal.pone.0123078] [Citation(s) in RCA: 46] [Impact Index Per Article: 5.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/08/2014] [Accepted: 02/27/2015] [Indexed: 01/18/2023] Open
Abstract
BACKGROUND For the treatment of depressive disorders, the framework of collaborative care has been recommended, which showed improved outcomes in the primary care sector. Yet, an earlier literature review did not find sufficient evidence to draw robust conclusions on the cost-effectiveness of collaborative care. PURPOSE To systematically review studies on the cost-effectiveness of collaborative care, compared with usual care for the treatment of patients with depressive disorders in primary care. METHODS A systematic literature search in major databases was conducted. Risk of bias was assessed using the Cochrane Collaboration's tool. Methodological quality of the articles was assessed using the Consensus on Health Economic Criteria (CHEC) list. To ensure comparability across studies, cost data were inflated to the year 2012 using country-specific gross domestic product inflation rates, and were adjusted to international dollars using purchasing power parities (PPP). RESULTS In total, 19 cost-effectiveness analyses were reviewed. The included studies had sample sizes between n = 65 to n = 1,801, and time horizons between six to 24 months. Between 42% and 89% of the CHEC quality criteria were fulfilled, and in only one study no risk of bias was identified. A societal perspective was used by five studies. Incremental costs per depression-free day ranged from dominance to US$PPP 64.89, and incremental costs per QALY from dominance to US$PPP 874,562. CONCLUSION Despite our review improved the comparability of study results, cost-effectiveness of collaborative care compared with usual care for the treatment of patients with depressive disorders in primary care is ambiguous depending on willingness to pay. A still considerable uncertainty, due to inconsistent methodological quality and results among included studies, suggests further cost-effectiveness analyses using QALYs as effect measures and a time horizon of at least 1 year.
Collapse
Affiliation(s)
- Thomas Grochtdreis
- Department of Health Economics and Health Services Research, Hamburg Center for Health Economics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| | - Christian Brettschneider
- Department of Health Economics and Health Services Research, Hamburg Center for Health Economics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| | - Annemarie Wegener
- Department of Health Economics and Health Services Research, Hamburg Center for Health Economics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| | - Birgit Watzke
- Clinical Psychology and Psychotherapy Research, Institute of Psychology, University of Zurich, Zurich, Switzerland
| | - Steffi Riedel-Heller
- Institute of Social Medicine, Occupational Health and Public Health, University of Leipzig, Leipzig, Germany
| | - Martin Härter
- Department of Medical Psychology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| | - Hans-Helmut König
- Department of Health Economics and Health Services Research, Hamburg Center for Health Economics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| |
Collapse
|
21
|
Zhang DX, Lewis G, Araya R, Tang WK, Mak WWS, Cheung FMC, Mercer SW, Griffiths SM, Woo J, Lee DTF, Kung K, Lam AT, Yip BHK, Wong SYS. Prevention of anxiety and depression in Chinese: a randomized clinical trial testing the effectiveness of a stepped care program in primary care. J Affect Disord 2014; 169:212-20. [PMID: 25216464 DOI: 10.1016/j.jad.2014.08.015] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/21/2014] [Revised: 07/30/2014] [Accepted: 08/08/2014] [Indexed: 10/24/2022]
Abstract
BACKGROUND Despite empirical evidence demonstrating the effectiveness of collaborative stepped care program (SCP) in Western countries, such programs have not been evaluated in the east, which has a different services system structure and cultural nuances in seeking help for mental illness. Furthermore, only a few studies have used SCP for depression and anxiety prevention. We conducted a trial to test its effectiveness in preventing major depressive disorder and generalized anxiety disorder among primary care patients with subthreshold depression and/or anxiety in Hong Kong. METHODS Subthreshold depression and/or anxiety patients were randomized into the SCP group (n=121) or care as usual (CAU) group (n=119). The SCP included watchful waiting, telephone counseling, problem solving therapy, and family doctor treatment within one year. The primary outcome was the onset of major depressive disorder or generalized anxiety disorder in 15 months. The secondary outcomes were depressive and anxiety symptoms, quality of life and time absent from work due to any illness. RESULTS Survival analysis showed no differences between the SCP and CAU groups (the cumulative probability of onset at 15 month was 23.1% in the SCP group and 20.5% in the CAU group; Hazard Ratio=1.62; 95% Confidence Interval: 0.82-3.18; p=0.16). No significant differences were found in secondary outcomes. LIMITATIONS Sample size might not have been large enough. CONCLUSIONS SCP did not show beneficial effect on depression/anxiety prevention compared with CAU in Hong Kong primary care. As a large majority of patients improved overtime without any intervention, we are not able to exclude the possibility that the intervention might be effective. Future studies would need to have a larger sample size and conduct on patients with more severe symptoms or perform a second screening.
Collapse
Affiliation(s)
- De Xing Zhang
- The Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong Special Administrative Region (HKSAR), Hong Kong, China
| | - Glyn Lewis
- Mental Health Sciences Unit, Faculty of Brain Sciences, University College London, United Kingdom
| | - Ricardo Araya
- Department of Population Health, London School of Hygiene & Tropical Medicine, United Kingdom
| | - Wai Kwong Tang
- Department of Psychiatry, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China
| | - Winnie Wing Sze Mak
- Department of Psychology, The Chinese University of Hong Kong, Hong Kong, China
| | | | | | - Sian Meryl Griffiths
- The Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong Special Administrative Region (HKSAR), Hong Kong, China
| | - Jean Woo
- Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China
| | - Diana Tze Fan Lee
- The Nethersole School of Nursing, The Chinese University of Hong Kong, Hong Kong, China
| | - Kenny Kung
- The Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong Special Administrative Region (HKSAR), Hong Kong, China
| | - Augustine Tsan Lam
- Department of Family Medicine, New Territories East Cluster, Hospital Authority, Hong Kong, China
| | - Benjamin Hon Kei Yip
- The Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong Special Administrative Region (HKSAR), Hong Kong, China
| | - Samuel Yeung Shan Wong
- The Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong Special Administrative Region (HKSAR), Hong Kong, China.
| |
Collapse
|
22
|
Gitlin LN, Roth DL, Huang J. Mediators of the impact of a home-based intervention (beat the blues) on depressive symptoms among older African Americans. Psychol Aging 2014; 29:601-11. [PMID: 25244479 DOI: 10.1037/a0036784] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
Abstract
Older African Americans (N = 208) with depressive symptoms were randomly assigned to a home-based nonpharmacologic intervention (Beat the Blues, or BTB) or wait-list control group. BTB was delivered by licensed social workers and involved up to 10 home visits focused on care management, referral and linkage, depression knowledge and efficacy in symptom recognition, instruction in stress reduction techniques, and behavioral activation through identification of personal goals and action plans for achieving them. Structured interviews by assessors masked to study assignment were used to assess changes in depressive symptoms (main trial endpoint), behavioral activation, depression knowledge, formal care service utilization, and anxiety (mediators) at baseline and 4 months. At 4 months, the intervention had a positive effect on depressive symptoms and all mediators except formal care service utilization. Structural equation models indicated that increased activation, enhanced depression knowledge, and decreased anxiety each independently mediated a significant proportion of the intervention's impact on depressive symptoms as assessed with 2 different measures (PHQ-9 and CES-D). These 3 factors also jointly explained over 60% of the intervention's total effect on both indicators of depressive symptoms. Our findings suggest that most of the impact of BTB on depressive symptoms is driven by enhancing activation or becoming active, reducing anxiety, and improving depression knowledge/efficacy. The intervention components appear to work in concert and may be mutually necessary for maximal benefits from treatment to occur. Implications for designing tailored interventions to address depressive symptoms among older African Americans are discussed.
Collapse
Affiliation(s)
- Laura N Gitlin
- School of Nursing Center for Innovative Care in Aging, Johns Hopkins University
| | - David L Roth
- Center on Aging and Health, Division of Geriatric Medicine and Gerontology, Johns Hopkins University
| | - Jin Huang
- Center on Aging and Health, Division of Geriatric Medicine and Gerontology, Johns Hopkins University
| |
Collapse
|
23
|
Sonntag M, König HH, Konnopka A. The estimation of utility weights in cost-utility analysis for mental disorders: a systematic review. PHARMACOECONOMICS 2013; 31:1131-54. [PMID: 24293216 DOI: 10.1007/s40273-013-0107-9] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/16/2023]
Abstract
OBJECTIVE To systematically review approaches and instruments used to derive utility weights in cost-utility analyses (CUAs) within the field of mental disorders and to identify factors that may have influenced the choice of the approach. METHODS We searched the databases DARE (Database of Abstracts of Reviews of Effects), NHS EED (National Health Service Economic Evaluation Database), HTA (Health Technology Assessment), and PubMed for CUAs. Studies were included if they were full economic evaluations and reported quality-adjusted life-years as the health outcome. Study characteristics and instruments used to estimate utility weights were described and a logistic regression analysis was conducted to identify factors associated with the choice of either the direct (e.g. standard gamble) or the preference-based measure (PBM) approach (e.g. EQ-5D). RESULTS We identified 227 CUAs with a maximum in 2009, 2010, and 2012. Most CUAs were conducted in depression, dementia, or psychosis, and came from the US or the UK, with the EQ-5D being the most frequently used instrument. The application of the direct approach was significantly associated with depression, psychosis, and model-based studies. The PBM approach was more likely to be used in recent studies, dementia, Europe, and empirical studies. Utility weights used in model-based studies were derived from only a small number of studies. LIMITATIONS We only searched four databases and did not evaluate the quality of the included studies. CONCLUSIONS Direct instruments and PBMs are used to elicit utility weights in CUAs with different frequencies regarding study type, mental disorder, and country.
Collapse
Affiliation(s)
- Michael Sonntag
- Department of Health Economics and Health Services Research, Hamburg Center for Health Economics, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany,
| | | | | |
Collapse
|